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• To our knowledge, this is the first study to test an intervention to facilitate shared 
decision making in this population.  
• Despite the national push for shared decision making in diabetes, this pilot study 
found no impact on patient confidence or adherence. 
• Patients were more conflicted about decisions after increased involvement in the care 
pathway.  
• Unexpectedly, we observed extremely high decisional confidence at baseline. This 
would appear to be in conflict with high morbidity and mortality rates.  
• This extremely high confidence may be indicative of little perceived need to engage 
in treatment pathways. This has important practice implications for future 
interventions.  
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Abstract 
 
Aims: This pilot study aimed to explore whether the use of an intervention to increase shared 
decision making (Decision Navigation) in patients with a diabetic foot ulcer increased: (i) 
decision self-efficacy and (ii) foot treatment adherence. 
Methods: Fifty six patients with a diabetic foot ulcer were randomised to receive Decision 
Navigation (N = 30) or usual care (N = 26). Primary outcomes included decision self-
efficacy, adherence to foot treatment as reported by the patient and adherence to foot 
treatment as reported by the clinician. Secondary outcomes included foot ulcer healing rate, 
health-related quality of life, decisional conflict and decision regret.  
Results: Despite patients' rating DN as very helpful, mixed ANOVAs revealed no differences 
in decision self-efficacy or adherence between those receiving DN and usual care. There were 
no differences between groups with regards to the secondary outcomes, with the exception of 
decision conflict which increased over time (12 weeks) for those receiving DN.  
Conclusions: An intervention which facilitated patient involvement in treatment decisions 
did not have any impact on decisional confidence or adherence to foot treatment. This does 
not provide support for the suggestion that personalised care can improve health-related 
outcomes at this progressed stage of the patient’s disease trajectory. We suggest that the 
diabetic foot population may benefit from interventions at any earlier stage following 
diagnosis aimed at increasing motivation to engage with care pathways, centred on 
challenging personal controllability beliefs. 
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Diabetic foot ulceration predicts a five year mortality of up to 55% from ulcer onset and up to 
74% post lower-leg amputation (1). National guidelines have directed towards a 
multidisciplinary approach in diabetic foot care with emphasis on the integration of 
psychological focus (2, 3). Shared decision-making between the healthcare professional and 
patient is currently poor in this population. Increased patient involvement in treatment 
decisions may improve health outcomes through improved quality of care and increased 
treatment adherence (4). 
 
Foot self-care and adherence to treatment 
The recovery trajectory of a diabetic foot ulcer is largely dependent on foot self-care 
behaviours and adherence to treatment regimens. On average, a diabetic foot ulcer takes 133 
days to heal (5). Those who do not adhere well to foot treatment may obtain a chronic ulcer 
and/or one which may worsen to the point of amputation. It has therefore been widely 
acknowledged that promoting patient engagement with treatments and self-care behaviours is 
central to improving health and clinical outcomes in this population (6).   
Over the past decade, the importance of psychological factors in predicting adherence and 
self-care behaviours has been recognised in diabetic foot research (7). Tailored interventions, 
personalised in line with patient’s treatment agenda and beliefs, must play an important role 
in improving these outcomes (8,9).  
 
Decision Navigation 
‘Decision navigation’ (DN) is a multi-component intervention designed to facilitate shared 
decision-making between a healthcare professional and patient in practice. It is built on 
techniques which have been shown to increase patient involvement in question asking and 
improve information recall (10,11). 
The main component of DN takes the form of an interview between the patient and a trained 
‘Navigator’ in order to form a consultation plan (written summary) of the patients’ 
questions/concerns relating to their care and treatment. This consultation plan is then used 
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within a routine appointment as an agenda with a healthcare professional. Audio recordings 
and a written document of the information discussed are generated and given to the patient.  
DN has previously been shown to enhance decisional confidence and certainty, as well as 
reduce decisional regret, in newly diagnosed prostate cancer patients faced with treatment 
choices (12). This intervention has traditionally been used with different groups of cancer 
patients (see www.SCOPED.org for further details). To our knowledge, DN had never been 
tested or implemented in patients with chronic conditions.  
 
The Current Study 
As highlighted previously, patients with a diabetic foot ulcer experience some of the poorest 
morbidity and mortality outcomes recorded in chronic illness (4). These patients are also 
faced with treatment decisions which often require increased urgency with measurable impact 
relative to the general diabetes population. For example, patients with a diabetic foot ulcer 
may need to make explicit treatment decisions surrounding amputation, plaster cast vs. 
specialist foot device or infection control methods. They may also need to make decisions 
which relate to quality of life vs. healing rate, e.g. the decision to take time out of 
employment/change employment in order to rest their foot and prevent future ulcers. To our 
knowledge, there has been no published research to date which tests shared decision making 
in the diabetic foot population.  
This pilot study primarily aimed to test whether the use of an intervention to facilitate shared 
decision-making (Decision Navigation) increased (a) decision self-efficacy and (b) adherence 
to foot treatment in patients with a diabetic foot ulcer.  
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Methodology 
 
Participants 
Participants were recruited from a single-site diabetes foot clinic in the Edinburgh Royal 
Infirmary, UK between 01/07/14 and 31/03/15. 
Patients who were newly diagnosed with a diabetic foot ulcer and/or considering a new 
treatment (as identified by a Consultant Clinician) and who did not display the normal 
anticipated healing rate were eligible. This was defined as ≤ 30% improvement in ulcer 
healing rate two weeks post initial contact with the diabetes foot clinic. Patients with any type 
of diabetes were eligible. Given a key aim of shared decision making is to promote 
personalised care, patients could be enrolled into other clinical studies trialling foot 
treatments (e.g. dressing treatment) as long as these formed part of their normal treatment 
decisions within the clinic.   
Patients were excluded who were: unable to give informed consent; displayed a severe 
ischemic foot ulcer; had an identifiable severe psychiatric morbidity; and/or were younger 
than 16 years old. 
 
Design 
This pilot study took the form of a randomised controlled trial testing the Decision 
Navigation intervention relative to usual care.  
 
Randomisation 
Group allocation sequence was determined by an external researcher through the use of a 
computerised generated random number table (www.randomizer.org). To ensure allocation 
concealment from the research team and participants, opaque, sealed envelopes were 
employed which contained a note of group allocation. Envelopes were opened by a member 
of the research team after baseline measures had been taken and group allocation was then 
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communicated to patients and the foot team. Due to the interactive nature of the intervention 
it was not possible for group allocation to be blinded. 
Procedures 
Ethical approval was obtained from the NHS South East Scotland Research Ethics 
Committee (ref 14/SS/0057).  
Patient eligibility was assessed by a consultant diabetes clinician.  All patients were 
approached by a consultant clinician or podiatrist who introduced the study. Patients were 
given an information pack to take away and read if they stated that they were interested in 
participating.  
At follow-up appointment in the foot clinic approximately 2 weeks later, a consultant 
clinician or podiatrist asked the patient whether they would like to participate. If the patient 
agreed, they were then introduced to the research team who took informed consent confirmed 
through written signature and baseline measures in person. Wherever possible, participants 
completed follow-up questionnaires as part of their attendance at the foot clinic. Some 
participants who had been discharged completed the 12 week follow-up questionnaires at 
home and returned them via postal mail. Ulcer measurements were taken as part of routine 
care and communicated to the research team by podiatrists.  
 
Control (Usual care) 
Patients allocated to the control group received standard care. This pathway typically took the 
following structure: (i) formal assessment of ulcer; (ii) treatment plan formed, most 
frequently incorporating the use of debridement, off-loading, infection control, and/or a 
vascular intervention; (iii) patient received treatment advice; and (iv) patient attended clinic 
at regular intervals for check-ups as advised by the clinician. 
 
Intervention (Decision Navigation) 
Patients in the intervention group received standard care along with Decision Navigation, 
which is a multi-component intervention developed to promote informed treatment decision 
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making (Table 1). Decision Navigation was delivered to patients by a trainee health 
psychologist and four assistant psychologists, who were formally trained in the methods by 
the founder of the intervention (Jeff Belkora). The training consisted of a two day course and 
weekly case reviews for a period of two months. Fidelity tests on the Navigated documents 
were also carried out by the founder of the methods for 5 months. Healthcare professionals 
were not trained in the methods; however the purpose of this intervention was to be feasible 
for implementation in routine practice and so Navigators were trained to provide assistance in 
facilitating the use of consultation plans between healthcare staff and patients where 
necessary.  
 
Descriptive Measures 
Measures of gender, age, ethnicity, marital status, education and employment were taken at 
baseline (table 1). Patient status was categorised as: (i) New Patient (ii) Reulcered Patient or 
(iii) Current Patient. New patients were defined as those who had entered the foot clinic for 
the first time; reulcered patients had been newly referred to the clinic for a second time or 
more; and current patients were those receiving ongoing foot treatment with a new decision 
to make. Time (days) between recruitment and exit from the study was calculated. 
 
Outcome Measures 
Table 2 provides an overview of measures, time points and example questions for all scales 
used in this study.  
Baseline is defined as immediately after recruitment but prior to group allocation. T1 is 
defined as during the next appointment at the foot clinic (approximately two weeks after 
recruitment). T2 is defined as 12-weeks post appointment.  
Decisional self-efficacy (DSE) (13), adherence to treatment as reported by the patient and 
adherence to treatment as reported by the clinician were our primary outcome measures. 
These were all measured at baseline and T2. DSE was additionally measured at T1.  
We chose three primary outcomes as we were interested in whether changing decision self-
efficacy would lead to a change in both clinician and patient rated adherence. In this 
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exploratory study we did not apply a weighting, however in a future study, as decision self-
efficacy is being targeted by the intervention, this variable should be used as the basis of the 
power calculation. 
Decision conflict (DC) (14), decision regret (DR) (15), wound healing rate, health-related 
quality of life (HR-QoL) (16) and patient acceptability of DN were our secondary outcome 
measures. Ulcer size and HR-QoL were measured at baseline and T2. DC was measured at 
T1 and T2. Patient acceptability (only measured intervention group) and DR were measured 
at T2 only.  
 
Statistical Analyses 
Data was coded and analysed using SPSS version 21, 2012.  
The key test of the primary hypotheses was whether the change over time differed between 
the groups, tested via a group by time interaction in the ANOVA for all primary outcome 
measures.  
Given that this was a pilot study, a key aim was to calculate effect sizes which could inform 
the justification and/or design of a larger trial. The sample size for this pilot was determined 
by practical considerations which centred on the recruitment time-frame available. 
 
Missing data 
The main analyses were conducted twice using both completer analysis and intention to treat 
analysis. In completer analysis, numbers analysed were reported for each outcome. Intention-
to-treat analysis was also conducted and reported separately, whereby baseline (last) scores 
were carried forward and entered in place of missing data for repeated measures (17).   
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Results 
 
Patients with a diabetic foot ulcer were randomly allocated to receive the additional service 
‘Decision Navigation’ (N = 30) or to receive usual care (N = 26).  
 
Demographics and Baseline Characteristics  
One hundred six individuals were invited to take part in the study; fifty-six consented and 
were randomised to the intervention or control group. Fifty-six data sets were analysed at T1 
and forty-nine data sets were analysed at T2 (seven lost to follow-up). See Figure 1.  
One-way ANOVA and Chi-square analyses revealed no significant differences between the 
intervention and control with regards to any descriptive measures (see Table 3). On this basis, 
no descriptive variables were entered as covariates in subsequent analyses. Baseline 
characteristics were also similar, with no significant differences yielded between groups.   
Time in the study did not significantly differ between control (M=99 days, SD=21.6) and 
intervention (M=97.6 days, SD=19.4), F(1,48)=.06, p=.815.  
The lack of differences between the intervention and control in demographics and baseline 
characteristics indicates that the randomisation process was effective.  
 
Primary outcomes  
A summary of the full statistical results is presented in Table 4. 
Mixed ANOVAs revealed non-significant group x time interactions for decision self-efficacy, 
p=.299, ηp²=.026, adherence as reported by the patient, p=.934, ηp²=<.001, and adherence as 
reported by the clinician p=.934 ηp²=<.001.  
Secondary outcomes 
A two-way mixed ANOVA (two time points) revealed a significant group x time interaction 
for decision conflict, p=.049, ηp²=.077. Post-hoc comparisons revealed that DC increased 
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from 17.1% at T1 to 23.27% at T2 in the group receiving DN, p= .042. No significant 
decrease in DC over time was observed in those receiving usual care.  
A mixed ANOVA (two time points) revealed a non-significant group x time interaction for 
health-related quality of life, p=.409, ηp²=.015.  
Between subjects ANOVAs revealed no significant differences for wound healing rate 
(difference in ulcer size over time), p=.461, ηp²=.013, or decision regret, p=.625, ηp²=.005. 
Mean scores on each facet of patient acceptability of DN (N=25) revealed that participants 
receiving DN rated the helpfulness of the treatment decision aid 8.4, the interview with a 
Navigator as 8.39, the audio recording of their consultation as 8.32 and the written summary 
as 8.75. Overall DN was rated as 8.32 for helpfulness. All means were scored out of 10. 
100% of participants reported that they would opt into using DN again and 100% reported 
they would recommend it to another diabetic foot patient.  
 
Intention-to-treat analysis (ITT) 
All primary and secondary outcomes were additionally analysed based on the initial treatment 
assignment. ITT analyses were consistent with the main completer analyses; there were no 
differences in the conclusions drawn. See Table 5 for ITT results.  
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Discussion 
The way in which Decision Navigation (DN) was implemented in patients with a diabetic 
foot ulcer was rated as acceptable and helpful. However, this yielded no statistically or 
practically significant differences with regards to decisional confidence or adherence to foot 
treatment. Although UK national guidance has pushed for increased patient involvement in 
treatment care pathways in this population (18), the results of this pilot study suggest that an 
intervention aimed at facilitating shared decision-making is not likely to impact patient foot 
behaviours at this progressed stage in the disease trajectory.  
Based on the extremely high existing decisional confidence observed in this study, we make 
the case that the diabetic foot population may benefit more from interventions focussed on 
building motivation to engage with treatment care pathways in the first instance, centred on 
challenging personal controllability beliefs, rather than the most commonly utilised approach 
to date of educational interventions aimed at improving confidence and treatment knowledge 
(19).  
 
Decision-making outcomes 
Based on psychological theories of behaviour it seemed logical to hypothesise that patient 
decision self-efficacy would be low at baseline due to the poor adherence and high mortality 
outcomes in the diabetic foot population (20,21). Traditionally, low self-efficacy predicts 
poor performance of behaviours (22). However, this study found that patients with a diabetic 
foot ulcer displayed a very high mean decision self-efficacy score of 83.5% at baseline. This 
would appear to be in conflict with the poor adherence and poor health outcomes observed in 
this population, which therefore presents the diabetic foot ulcer population as a more unusual 
case. These individuals appeared to be extremely confident in their ability to source 
information relevant to their treatment and care; however the objective figures from research 
imply that their actions do not reflect this. The very high decision self-efficacy observed in 
this study could help to explain why the findings differed from previous research where the 
same DN intervention was shown to increase decision self-efficacy in prostate cancer patients 
(12). It is possible that patients with a diabetic foot ulcer may have perceived little need to 
engage in the treatment decision-making process via very high existing confidence that their 
decisions and involvement in foot care pathways were adequate.  
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This is an important consideration as to date most diabetic foot research has developed 
educational interventions and materials with the aim of increasing knowledge and patient 
confidence in relation to the self-care for their foot. However, the findings of this study 
instead suggest that interventions aimed at increasing motivation to engage in treatment 
pathways, rather than building self-efficacy and knowledge around them, may be more 
helpful for this population. It could also help explain why behaviour change attempts using 
this approach in this population to date have not been fruitful (19). It is important that future 
interventions are tailored and tested in line with this information. 
 
A further point which supports this notion is, whereas the Hacking et al (12) study found that 
DN reduced decisional conflict, this study found that the DN intervention significantly 
increased decisional conflict over time (12 week period). In other words, this intervention 
resulted in patients who were more conflicted despite the aim of easing the decision process. 
This is particularly interesting given this is inconsistent with what would be expected when 
implementing an intervention to facilitate shared decision making. 
In an attempt to make sense of this finding, we speculate that this population may have 
displayed a "low internal health locus of control"; this has also been suggested in previous 
diabetic foot research (23). This psychological term is used to describe a set of characteristics 
whereby an individual may believe that there is little that they can personally control in their 
care/recovery pathway (e.g. self-care at home) and may place far heavier weighting on 
external factors (e.g. health services/professionals). This could present a profile of a group 
who have had a long term condition for some time and who may attend and/or over-engage in 
health service appointments, yet do not appear to recover as would be expected due to a lack 
of adherence to prescribed treatment and/or self-care behaviours. In the context of the 
increased decision conflict over time as a result of DN, the action of prompting this patient 
group to independently consider their personal treatment options may have created the 
perception of choices where there were none previously; i.e. the intervention may have 
increased decisional conflict via challenging personal controllability beliefs. For example, the 
belief that treatment decisions lay fully with the healthcare team may have been challenged 
via the intervention actively presenting that treatment decisions were negated by the patient 
through use of the question list. In line with this view, the increased decisional conflict 
observed may have been a result of patients engaging in a learning process. These 
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mechanisms are, however, hypothetical as the study methodology was not designed to detect 
controllability beliefs and there is not currently enough psychological literature in this 
population to draw from. We recommend that future studies should incorporate measures of 
controllability beliefs and include patients who have recently been diagnosed as well as those 
who have more advanced conditions(25). 
 
Behavioural and clinical outcomes 
This pilot study found no evidence to support DN as a method for improving adherence to 
treatment or wound healing.   
In order for these outcomes to have improved, it was hypothesised that DN would need to 
have (i) increased decision self-efficacy to promote a direct link with patient treatment 
engagement and/or (ii) corrected illness or treatment misconceptions via personalised 
education from the healthcare team (22, 24). Given that DN had no impact on decision self-
efficacy, then it is no surprise that adherence to treatment did not differ.  
 
Limitations 
The DN intervention is a facilitative method and thus no direct information was offered by 
the Navigators delivering it. The effectiveness of DN was therefore largely dependent on the 
clinicians' and patients’ engagement with it. No training was provided to the healthcare team 
involved in this project with regards to delivery of shared care and/or behaviour change. In 
order to maximise the likelihood of reaching behavioural outcomes, it would be useful for 
future studies adopting interventions which present with the opportunity for behaviour 
modification to provide training to those involved in relevant methods, e.g. Motivational 
Interviewing (26).  
It is also worth noting that within the patient and clinician-reported adherence questionnaires, 
the five facets of the foot treatments were equally weighted in the scoring procedures. 
However, it is likely that certain treatments, such as antibiotics, required higher weighting 
due to increased patient self-monitoring and larger clinical effects on health outcomes. The 
patient adherence measure developed for this study yielded a low alpha-coefficient of 0.43. 
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This highlights the need for development of a validated and reliable tool for measuring 
adherence in this population.  
It is also possible that there were ceiling effects with regards to the primary outcome 
measures. DSE and adherence to treatment measures were all >80% at baseline meaning that 
increases would have been difficult. These difficulties in detecting differences would have 
been amplified as this pilot study had a small sample size and thus was underpowered.  
This study was also limited to one site in the Royal Infirmary of Edinburgh, which performed 
well in national audits on clinical outcomes. The sample also consisted of 100% white British 
participants and was limited to those who agreed to participate. This limits the degree to 
which the finding can be generalised to the diabetic foot population. The individuals and 
healthcare teams who may benefit most from this type of intervention may not have been 
captured through the sample yielded in this study. The small sample size also limits the 
representativeness of the findings to the wider diabetic foot population.  
 
Sample Size 
A key aim of this pilot study was to justify and/or inform the design of a larger trial. Based on 
the very small effect sizes observed across all outcomes, we think it is  is unlikely that this 
intervention would yield clinically meaningful treatment effects in a subsequent large 
adequately powered trial.  We suggest that future interventions aimed at increasing 
motivation to engage in treatment pathways are worthy of further evaluation in this 
population. 
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Table 1 –– Decision Navigation (intervention) structure adopted in this study 
Decision Navigation 
(i) Information 
booklet (treatment 
decision aid) 
 
Participants received an adapted NHS Scotland information booklet in 
the form of a treatment decision aid at baseline, which contained a 
breakdown of common treatment options as indicated by the Scottish 
Diabetes Foot Action Group. The adapted booklet additionally 
contained lists of advantages and disadvantages associated with 
different treatment choices, with content collaboratively developed and 
approved by the diabetes foot care team at the Edinburgh Royal 
Infirmary, NHS Lothian.  
(ii) Personalised 
patient goals 
Approximately one week after recruitment, patients received a 
telephone call covering a semi-structured interview from a 'Navigator' 
(trained assistant psychologist or trainee health psychologist). Further 
details on the interview process can be found at www.scoped.org. 
Navigators worked collaboratively with the patient to produce a 
‘consultation plan’, which is an agenda covering the areas for 
discussion during the next consultation. This consultation plan was 
facilitated by the Navigator but developed, edited and approved by the 
patient. The Navigator forwarded the consultation plan to the clinician 
in advance of their next scheduled foot appointment.  
(iii) Consultation  The Navigator accompanied the patient to their scheduled appointment 
with the consultant foot care clinician, which was approximately 2 
weeks post recruitment. The Navigator also audio recorded the 
consultation and encouraged both the patient and physician to make 
use of the consultation plan.   
(iv) Audio 
recording and 
written summary 
 
At the end of the consultation appointment, the patient received an 
audio copy of the consultation in the form of a compact disc. Post 
consultation, the navigator produced a written summary of the main 
points discussed in accordance with the questions raised through the 
consultation plan. The final version was approved by the consultant 
clinician. This written summary was sent to the patient approximately 3 
days after the consultation.  
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Table 2 –– A summary of outcomes measures.  
 Description Time points measured Example Questions 
Decisional Self-
Efficacy 
11-item 
questionnaire  
Scored out of 
100% 
The Decisional Self-Efficacy Scale 
(DSE) is a validated tool used to assess 
self-confidence in decision making (13). 
Baseline (immediately before group 
allocation) 
Immediately before appointment- 
this was after the formation of the 
consultation plan but prior to 
discussing the questions with the 
foot team for the intervention 
group, and prior to the next routine 
appointment for the control. DSE 
was measured specifically at this 
time point given we were interested 
in patients’ decision self-efficacy 
related to their personal ability to 
source information and not as a 
result of the doctor’s discussion. 
12-weeks post appointment. 
I feel confident that I can get facts about 
the benefits of each choice.  
I feel confident that I can ask for advice.  
I feel confident that I can figure out the 
choice that best suits me. 
Adherence  
(clinician 
perspective) 
5-item 
questionnaire 
developed for the 
study 
Scored out of 
100% 
The clinician's treatment adherence 
questionnaire took the same structure as 
the patient adherence questionnaire, but 
was completed from the clinician's 
perspective. This scale was developed for 
this study and produced an Alpha 
Coefficient of 0.77. 
Baseline (immediately before group 
allocation) 
12- weeks post appointment 
In your clinical judgement the patient… 
Rests his/her ulcerated foot. 
Attends dressing change appointments. 
Wears his/her specialist foot device.  
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Adherence  
(patient 
perspective) 
5-item 
questionnaire 
developed for the 
study 
Scored out of 
100% 
Patient treatment adherence was 
measured using a five-item questionnaire, 
considering the most common foot 
treatments: foot rest, antibiotic treatment, 
specialist foot devices, specialist shoes, 
and dressing changes. This scale was 
developed for this study and produced an 
Alpha Coefficient of 0.43. 
Baseline (immediately before group 
allocation) 
12- weeks post appointment 
I rest my ulcerated foot 
I wear the specialist foot device given to 
me 
I take the antibiotics given to me by my 
diabetes foot doctor 
Decision 
Conflict 
16-item 
questionnaire 
Scored out of 
100% 
The Decisional Conflict Scale (DCS) is 
used to assess decisional uncertainty and 
perceived effectiveness of decision 
making (14). 
Immediately after appointment- 
after discussion of the consultation 
plan for the intervention group or 
after the next routine appointment 
for the control 
12-weeks post appointment 
I feel sure about what to choose.  
I have enough advice to make a choice. 
I am clear about which is more important 
to me (the benefits or the risks and side 
effects). 
Decision Regret 
5-item 
questionnaire 
Scored out of 
100% 
The Decisional Regret Scale (DR) is used 
to measure distress/remorse after a 
decision (15). 
12-weeks post appointment It was the right decision. 
I regret that I made that choice. 
The decision was a wise one.  
Wound Healing 
Rate 
 
Wound (ulcer) healing rate was 
determined by measuring the change in 
ulcer size between baseline and twelve 
week follow-up .The clinician/podiatrist 
traced the perimeter of the ulcer using 
acetate film and a fine-tipped black ink 
marker. The wound was measured 
through means of planimetry, which 
describes the greatest length of wound 
multiplied by the greatest width of wound 
(cm) to give a total in cm². 
Baseline (immediately before group 
allocation) 
12-weeks post appointment 
N/A 
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If more than one ulcer was present, the 
same methods were used for each wound 
individually and an overall mean healing 
rate was calculated and recorded in the 
final figures. 
Health-related  
Quality of Life 
Health-related quality of life was 
measured using the European Quality of 
Life Scale (EQ-5D) (16).   
Baseline (immediately before group 
allocation) 
12-weeks post appointment 
Under each heading, please tick the ONE 
box that best describes your health 
TODAY for mobility/ self-care/ usual 
acitivites/ pain & discomfort/ anxiety & 
depression. E.g… 
I have severe problems to walk about.  
I am able to walk about.    
Patient 
Acceptability of 
DN 
 
Patient acceptability of the DN 
intervention was measured using a seven-
item self-report questionnaire developed 
for this study. It asked participants to rate 
each component of the intervention for 
helpfulness on a 10-point Likert scale 
(decision aid; interview with a Navigator; 
audio recording; written summary; and 
DN overall). It also asked participants to 
answer yes/no/unsure to whether they 
would opt to using Navigation again and 
whether they would recommend it to 
another patient with a foot ulcer. 
Participants in the intervention group 
completed this measure at twelve weeks 
post-consultation. 
12-weeks post appointment  How helpful did you find the telephone 
call with the Navigator? 
How helpful did you find the written 
summary of your consultation? 
If given the opportunity, would you use 
Decision Navigation again in the future? 
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Table 3 –– Baseline demographics for control and intervention group 
 Total 
 (N = 56) 
Control  
(N =26) 
Intervention  
(N =30) 
Analyses 
    
Ethnicity  
   White British 
 
    100% 
 
    100% 
 
 
Mean Age 
   Years (SD) 
 
 
59.5 (9.9) 
 
 
62.5 (14.98) 
 
 
F(1,54)=.77, p=.384 
 
Employment 
    Full-time 
    Part-time 
    Retired 
    Unemployed 
    Student 
    Other 
 
 
 23.1% 
 11.5% 
 46.2% 
   7.7% 
   3.8% 
   7.7% 
 
 
 16.7% 
   3.3% 
 63.3% 
 13.3% 
 -- 
   3.3% 
 
 
 
X²(5, N=56)=4.4, 
p=.492 
 
 
Education 
    Before 15 
    Secondary 
    College 
    University 
 
 
 11.5% 
 26.9% 
 26.9% 
 34.6% 
 
 
 20.0% 
 33.3% 
 23.3% 
 23.3% 
 
 
 
X²(3, N=56)=1.5, 
p=.682 
 
 
Marital status 
    Married 
    Partner 
    Divorced 
    Separated  
    Widowed  
    Single 
 
 
 53.8% 
   7.7% 
   7.7% 
   3.8% 
 11.5% 
 15.4% 
 
 
 60.0% 
   6.7% 
   6.7% 
   6.7% 
 -- 
 20.0% 
 
 
 
X²(5, N=56)=3.97, 
p=.554 
 
 
Gender (male) 
 
 73.1% 
 
 73.3% 
 
X²(1, N=56)= <.001, 
p=.983 
 
 
Patient status 
    New  
    Current  
    Reulcered 
 
 
 53.8% 
 26.9% 
 19.2% 
 
 
 63.3% 
 16.7% 
 20.0% 
 
 
 
X²(2, N=56)=.9, 
p=.637 
 
X² = Chi-squared analysis. F = One-way ANOVA.  
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Table 4 –– Summary of primary and secondary completer analyses 
 Baseline 
(T0) 
Next appointment 
(T1) 
12 weeks 
(T2) 
Group Time Group x Time 
Decision Self-efficacy     
Control       (N= 23) 
Intervention (N= 25) 
 
83.03 (19.9) 
83.9 (13.9) 
 
81.4 (18.46) 
87.45 (11.33) 
 
86.88 (16.69) 
93.18 (7.1) 
  
F=1.39, p=.245 
ηp²=.03 
 
F=6.58, p=.002 
ηp²=.127 
 
F=1.22, p=.299 
ηp²=.026 
Adherence (clinician) 
Control        (N=21) 
Intervention (N=26) 
 
81.75 (13.32) 
76.03 (17.42) 
 
        -- 
 
 
85.13 (12.66) 
79.2 (17.16) 
 
F=3.15, p=.083 
ηp²=.067 
 
F=.86, p=.358 
ηp²=.019 
 
F=.007, p=.934 
ηp²=<.001 
Adherence (patient) 
Control        (N=22) 
Intervention (N=25) 
 
82.13 (11.01) 
83.52 (10.68) 
 
        -- 
 
87 (9.36) 
86.08 (9.45) 
 
F=.001, p=.976 
ηp²=<.001 
 
F=4.8, p=.034 
ηp²=.096 
 
F=.247, p=.622 
ηp²=.005 
Decision Conflict 
Control        (N=23) 
Intervention (N=25) 
 
         -- 
 
21.94 (18.08) 
17.1 (15.17) 
 
18.53 (16.07) 
23.75 (15.34) 
 
F=.002, p=.962 
ηp²=<.001 
 
F=.377, p=.543 
ηp²=.008 
 
F=3.68, p=.049 
ηp²=.077 
Decision Regret 
Control        (N=22) 
Intervention (N=25) 
 
         -- 
 
        -- 
 
38.4 (17) 
40.4 (10.3) 
 
F=.242, p=.625 
ηp²=.005 
 
      -- 
 
        -- 
Healing Rate 
Control        (N=20) 
Intervention (N=25) 
 
         -- 
 
        -- 
 
       -- 
 
F=.553, p=.461 
ηp²=.013 
 
      -- 
 
        -- 
Health-Related Quality  
of Life 
 Control        (N=23) 
 Intervention (N=26) 
 
 
68.48 (22.53) 
70.19 (20.71) 
 
         
        -- 
 
 
64.13 (23.92) 
69.42 (21.28) 
 
 
F=.348, p=.558 
ηp²=.007 
 
 
F=1.42, p=.24 
ηp²=.029 
 
 
F=.693, p=.409 
ηp²=.015 
Incomplete or missing data sets were removed from analyses. Mean (Standard Deviation): all scores can be interpreted as percentages. 
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Table 5 –– Summary of primary and secondary intention-to-treat analyses.  
 Baseline 
(T0) 
Next healthcare 
appointment (T1) 
12 weeks 
(T2) 
Group Time Group x Time 
Decision Self-efficacy     
 Control        (N=26) 
Intervention (N=30) 
 
83.28 (18.9) 
83.94 (17) 
 
80.24 (20.18) 
87.05 (13.86) 
 
86.01 (15.85) 
91.67 (13.52) 
  
F=1.23, p=.272 
ηp²=.022 
 
F=5.67, p=.005 
ηp²=.095 
 
F=1.67, p=.194 
ηp²=.03 
Adherence (clinician) 
Control         (N=23) 
Intervention (N=29) 
 
81.23 (14.64) 
75.9 (16.84) 
 
        -- 
 
 
84.17 (14.28) 
78.42 (16.94) 
 
F=2.8, p=.1 
ηp²=.053 
 
F=.86, p=.358 
ηp²=.017 
 
F=.005, p=.945 
ηp²=<.001 
Adherence (patient) 
Control         (N=26) 
Intervention (N=30) 
 
83.03 (10.39) 
83.18 (10.63) 
 
        -- 
 
86.62 (9.12) 
85.32 (9.83) 
 
F=.058, p=.811 
ηp²=.001 
 
F=4.83, p=.032 
ηp²=.084 
 
F=.308, p=.581 
ηp²=.006 
Decision Conflict 
Control          (N=23) 
Intervention  (N=27) 
 
         -- 
 
22.21 (17.27) 
18.09 (15.19) 
 
19.09 (15.12) 
24.28 (15.08) 
 
F=.02, p=.887 
ηp²=<.001 
 
F=.401, p=.53 
ηp²=.008 
 
F=3.71, p=.048 
ηp²=.072 
Decision Regret 
Control          (N=22) 
Intervention  (N=25) 
 
         -- 
 
        -- 
 
38.4 (17) 
40.4 (10.3) 
 
F=.242, p=.625 
ηp²=.005 
 
      -- 
 
        -- 
Healing Rate 
Control          (N=24) 
Intervention  (N=26) 
 
         -- 
 
        -- 
 
       -- 
 
F=.256, p=.615 
ηp²=.005 
 
      -- 
 
        -- 
Health-Related QoL  
 Control          (N=26) 
 Intervention   (N=30) 
 
67.5 (21.64) 
69.67 (20.05) 
 
         
        -- 
 
63.65 (22.78) 
69.17 (20.05) 
 
F=.528, p=.47 
ηp²=.01 
 
F=1.37, p=.253 
ηp²=.024 
 
F=.792, p=.377 
ηp²=.014 
Note.  Baseline (last) scores were entered in place of missing data. Mean (Standard Deviation): all scores can be interpreted as percentages.
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